Ontario Prepares for Respiratory Illness Season
As fall sets in, Ontario braces for rising COVID-19, flu, RSV, and measles cases. Experts stress vaccinations for high-risk groups and updated routine immunizations. Doctors recommend hand hygiene, masks in crowded areas, and staying home when sick to protect communities during the seasonal surge of respiratory illnesses.
Rising Homelessness Among Canadian Seniors
Shelters across Canada report a sharp increase in seniors experiencing homelessness, often linked to fixed incomes, rising costs, and health needs. Many face homelessness for the first time after age 55, requiring specialized supports. Experts warn of “accelerated aging” and call for better housing and care solutions.
Nasal Spray Shows Promise Against COVID-19
A study suggests azelastine nasal spray could lower COVID-19 and other respiratory infections. While results are encouraging, the spray isn’t FDA-approved for prevention and should not replace vaccines or masks. Researchers say larger studies are needed to confirm effectiveness and safety in reducing infections.
The Risks of Too Much Protein
Protein is vital for muscle, hormones, and immunity, but excessive intake may cause weight gain or digestive issues like constipation if not balanced with fibre. Experts recommend focusing on both nutrients—such as in the Mediterranean diet—to support overall health, weight management, and longevity.
Salmonella Outbreak Triggers Pistachio Recalls
The Canadian Food Inspection Agency has recalled multiple pistachio products, including baklava, ice cream, and trendy Dubai brand chocolates, after a salmonella outbreak sickened 62 people across Canada. Consumers are urged to avoid affected products, as salmonella can cause serious illness—especially in children, seniors, and immunocompromised individuals.
Neuralink Brain Implants Tested in Canada
Two Canadian men with spinal cord injuries received Neuralink brain implants, allowing them to control a computer cursor with thought. The trial, led at Toronto Western Hospital, marks the first outside the U.S. While promising, experts caution against “false hope,” noting risks and long timelines before widespread use.